Tarsus Pharmaceuticals
TARS
TARS
51 hedge funds and large institutions have $222M invested in Tarsus Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 19 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
24% less capital invested
Capital invested by funds: $294M → $222M (-$72M)
42% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 19
Holders
51
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.05M | |
| 2 | +$547K | |
| 3 | +$422K | |
| 4 |
CAC
Cowen and Company
New York
|
+$340K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$334K |
Top Sellers
| 1 | -$31.9M | |
| 2 | -$2.89M | |
| 3 | -$841K | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$460K |
| 5 |
JG
Jefferies Group
New York
|
-$340K |